Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report
Gestational alloimmune liver disease is a rare complication associated with reactive maternal immunoglobulins resulting in neonatal liver pathology. The mainstay treatment for prevention in future pregnancies is intravenous immunoglobulins. Although relatively well tolerated, adverse reactions may o...
Main Authors: | Minhazur Sarker, Chelsea DeBolt, Noel Strong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Case Reports in Women's Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221491122200042X |
Similar Items
-
Successful pregnancy outcomes following intravenous immunoglobulin treatment in a woman with a previous fetal death in utero due to gestational alloimmune liver disease: A case report
by: Rebecca Moorhead, et al.
Published: (2022-07-01) -
Pregnant Women at Low Risk of Having a Child with Fetal and Neonatal Alloimmune Thrombocytopenia Do Not Require Treatment with Intravenous Immunoglobulin
by: Jens Kjeldsen-Kragh, et al.
Published: (2023-08-01) -
Neonatal and fetal alloimmune thrombocytopenia
by: Ioana Emanuela Atanasescu, et al.
Published: (2022-06-01) -
Linezolid-induced pancytopenia and hyponatremia
by: Satish Kumar, et al.
Published: (2022-01-01) -
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)